Report Detail
COVID-19 Impact on Global Sustained Release Injectables Market Insights, Forecast to 2026
- RnM4070244 |
- 19 June, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Medical Devices & Consumables
Sustained Release Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sustained Release Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Sustained Release Injectables market is segmented into
Naltrexone
Exenatide
Estradiol
Other
Segment by Application, the Sustained Release Injectables market is segmented into
Diabetes
Leukemia
Acromegaly
Other
Regional and Country-level Analysis
The Sustained Release Injectables market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sustained Release Injectables market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Sustained Release Injectables Market Share Analysis
Sustained Release Injectables market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Sustained Release Injectables by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Sustained Release Injectables business, the date to enter into the Sustained Release Injectables market, Sustained Release Injectables product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Eli Lilly
Sanofi
Roche
Novartis
Aurobindo
Avadel
Biomarin
Camurus
Critical Pharmaceuticals
Alkermes
Amylin
Ascendis Pharma
1 Study Coverage
- 1.1 Sustained Release Injectables Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Sustained Release Injectables Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Sustained Release Injectables Market Size Growth Rate by Type
- 1.4.2 Naltrexone
- 1.4.3 Exenatide
- 1.4.4 Estradiol
- 1.4.5 Other
- 1.5 Market by Application
- 1.5.1 Global Sustained Release Injectables Market Size Growth Rate by Application
- 1.5.2 Diabetes
- 1.5.3 Leukemia
- 1.5.4 Acromegaly
- 1.5.5 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Sustained Release Injectables Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Sustained Release Injectables Industry
- 1.6.1.1 Sustained Release Injectables Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Sustained Release Injectables Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Sustained Release Injectables Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Sustained Release Injectables Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Sustained Release Injectables Market Size Estimates and Forecasts
- 2.1.1 Global Sustained Release Injectables Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Sustained Release Injectables Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Sustained Release Injectables Production Estimates and Forecasts 2015-2026
- 2.2 Global Sustained Release Injectables Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Sustained Release Injectables Manufacturers Geographical Distribution
- 2.4 Key Trends for Sustained Release Injectables Markets & Products
- 2.5 Primary Interviews with Key Sustained Release Injectables Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Sustained Release Injectables Manufacturers by Production Capacity
- 3.1.1 Global Top Sustained Release Injectables Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Sustained Release Injectables Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Sustained Release Injectables Manufacturers Market Share by Production
- 3.2 Global Top Sustained Release Injectables Manufacturers by Revenue
- 3.2.1 Global Top Sustained Release Injectables Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Sustained Release Injectables Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Sustained Release Injectables Revenue in 2019
- 3.3 Global Sustained Release Injectables Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Sustained Release Injectables Production by Regions
- 4.1 Global Sustained Release Injectables Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Sustained Release Injectables Regions by Production (2015-2020)
- 4.1.2 Global Top Sustained Release Injectables Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Sustained Release Injectables Production (2015-2020)
- 4.2.2 North America Sustained Release Injectables Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Sustained Release Injectables Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Sustained Release Injectables Production (2015-2020)
- 4.3.2 Europe Sustained Release Injectables Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Sustained Release Injectables Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Sustained Release Injectables Production (2015-2020)
- 4.4.2 China Sustained Release Injectables Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Sustained Release Injectables Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Sustained Release Injectables Production (2015-2020)
- 4.5.2 Japan Sustained Release Injectables Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Sustained Release Injectables Import & Export (2015-2020)
5 Sustained Release Injectables Consumption by Region
- 5.1 Global Top Sustained Release Injectables Regions by Consumption
- 5.1.1 Global Top Sustained Release Injectables Regions by Consumption (2015-2020)
- 5.1.2 Global Top Sustained Release Injectables Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Sustained Release Injectables Consumption by Application
- 5.2.2 North America Sustained Release Injectables Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Sustained Release Injectables Consumption by Application
- 5.3.2 Europe Sustained Release Injectables Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Sustained Release Injectables Consumption by Application
- 5.4.2 Asia Pacific Sustained Release Injectables Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Sustained Release Injectables Consumption by Application
- 5.5.2 Central & South America Sustained Release Injectables Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Sustained Release Injectables Consumption by Application
- 5.6.2 Middle East and Africa Sustained Release Injectables Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Sustained Release Injectables Market Size by Type (2015-2020)
- 6.1.1 Global Sustained Release Injectables Production by Type (2015-2020)
- 6.1.2 Global Sustained Release Injectables Revenue by Type (2015-2020)
- 6.1.3 Sustained Release Injectables Price by Type (2015-2020)
- 6.2 Global Sustained Release Injectables Market Forecast by Type (2021-2026)
- 6.2.1 Global Sustained Release Injectables Production Forecast by Type (2021-2026)
- 6.2.2 Global Sustained Release Injectables Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Sustained Release Injectables Price Forecast by Type (2021-2026)
- 6.3 Global Sustained Release Injectables Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Sustained Release Injectables Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Sustained Release Injectables Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 AstraZeneca
- 8.1.1 AstraZeneca Corporation Information
- 8.1.2 AstraZeneca Overview and Its Total Revenue
- 8.1.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 AstraZeneca Product Description
- 8.1.5 AstraZeneca Recent Development
- 8.2 Eli Lilly
- 8.2.1 Eli Lilly Corporation Information
- 8.2.2 Eli Lilly Overview and Its Total Revenue
- 8.2.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 Eli Lilly Product Description
- 8.2.5 Eli Lilly Recent Development
- 8.3 Sanofi
- 8.3.1 Sanofi Corporation Information
- 8.3.2 Sanofi Overview and Its Total Revenue
- 8.3.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 Sanofi Product Description
- 8.3.5 Sanofi Recent Development
- 8.4 Roche
- 8.4.1 Roche Corporation Information
- 8.4.2 Roche Overview and Its Total Revenue
- 8.4.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 Roche Product Description
- 8.4.5 Roche Recent Development
- 8.5 Novartis
- 8.5.1 Novartis Corporation Information
- 8.5.2 Novartis Overview and Its Total Revenue
- 8.5.3 Novartis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Novartis Product Description
- 8.5.5 Novartis Recent Development
- 8.6 Aurobindo
- 8.6.1 Aurobindo Corporation Information
- 8.6.2 Aurobindo Overview and Its Total Revenue
- 8.6.3 Aurobindo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 Aurobindo Product Description
- 8.6.5 Aurobindo Recent Development
- 8.7 Avadel
- 8.7.1 Avadel Corporation Information
- 8.7.2 Avadel Overview and Its Total Revenue
- 8.7.3 Avadel Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Avadel Product Description
- 8.7.5 Avadel Recent Development
- 8.8 Biomarin
- 8.8.1 Biomarin Corporation Information
- 8.8.2 Biomarin Overview and Its Total Revenue
- 8.8.3 Biomarin Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 Biomarin Product Description
- 8.8.5 Biomarin Recent Development
- 8.9 Camurus
- 8.9.1 Camurus Corporation Information
- 8.9.2 Camurus Overview and Its Total Revenue
- 8.9.3 Camurus Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 Camurus Product Description
- 8.9.5 Camurus Recent Development
- 8.10 Critical Pharmaceuticals
- 8.10.1 Critical Pharmaceuticals Corporation Information
- 8.10.2 Critical Pharmaceuticals Overview and Its Total Revenue
- 8.10.3 Critical Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 Critical Pharmaceuticals Product Description
- 8.10.5 Critical Pharmaceuticals Recent Development
- 8.11 Alkermes
- 8.11.1 Alkermes Corporation Information
- 8.11.2 Alkermes Overview and Its Total Revenue
- 8.11.3 Alkermes Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.11.4 Alkermes Product Description
- 8.11.5 Alkermes Recent Development
- 8.12 Amylin
- 8.12.1 Amylin Corporation Information
- 8.12.2 Amylin Overview and Its Total Revenue
- 8.12.3 Amylin Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.12.4 Amylin Product Description
- 8.12.5 Amylin Recent Development
- 8.13 Ascendis Pharma
- 8.13.1 Ascendis Pharma Corporation Information
- 8.13.2 Ascendis Pharma Overview and Its Total Revenue
- 8.13.3 Ascendis Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.13.4 Ascendis Pharma Product Description
- 8.13.5 Ascendis Pharma Recent Development
- 8.14 Taiwan Liposome Company
- 8.14.1 Taiwan Liposome Company Corporation Information
- 8.14.2 Taiwan Liposome Company Overview and Its Total Revenue
- 8.14.3 Taiwan Liposome Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.14.4 Taiwan Liposome Company Product Description
- 8.14.5 Taiwan Liposome Company Recent Development
9 Production Forecasts by Regions
- 9.1 Global Top Sustained Release Injectables Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Sustained Release Injectables Regions Forecast by Production (2021-2026)
- 9.3 Key Sustained Release Injectables Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Sustained Release Injectables Consumption Forecast by Region
- 10.1 Global Sustained Release Injectables Consumption Forecast by Region (2021-2026)
- 10.2 North America Sustained Release Injectables Consumption Forecast by Region (2021-2026)
- 10.3 Europe Sustained Release Injectables Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Sustained Release Injectables Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Sustained Release Injectables Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Sustained Release Injectables Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Sustained Release Injectables Sales Channels
- 11.2.2 Sustained Release Injectables Distributors
- 11.3 Sustained Release Injectables Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Market Opportunities and Drivers
- 12.2 Market Challenges
- 12.3 Market Risks/Restraints
- 12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Sustained Release Injectables Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Sustained Release Injectables. Industry analysis & Market Report on COVID-19 Impact on Global Sustained Release Injectables is a syndicated market report, published as COVID-19 Impact on Global Sustained Release Injectables Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Sustained Release Injectables market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
